PK

Pramod Kumar

Active Director Director DIN 09015416
DIN 09015416 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Pramod Kumar

Data last updated:

Pramod Kumar is a Director at Mapcure Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Mapcure Pharmaceuticals Private Limited reported revenue of ₹4.7 Lakh (FY 2024).

DIN 09015416
Primary Designation Director
Industry Chemicals
First Appointment 30 Dec 2020
Oldest Company Age 5 yrs
Largest company Mapcure Pharmaceuticals Private Limited · ₹4.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Dec 20202020₹4.7 Lakh (FY 2024)Active

Board colleagues of Pramod Kumar

Directorship timeline

Open interactive timeline →
Mapcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pramod Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pramod Kumar

Pramod Kumar currently holds 1 directorship: Mapcure Pharmaceuticals Private Limited (Director, since 30 Dec 2020, revenue ₹4.7 Lakh (FY 2024)).

Pramod Kumar was first appointed on 30 Dec 2020 as Director at Mapcure Pharmaceuticals Private Limited.

The current boards of Pramod Kumar's companies include Abhishek Vishwakarma (Mapcure Pharmaceuticals Private Limited), Shailini Raghuvanshi (Mapcure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available